Medtronic has entered into a distribution agreement with Merit Medical Systems to offer FDA-cleared ViaVerte — a minimally invasive and implant free basivertebral nerve ablation (BVNA) system.
It includes a physician-controlled steerable mechanism for precise basivertebral nerve targeting for treating chronic vertebrogenic lower back pain.
This agreement expands the ongoing relationship between Medtronic and Merit. Merit currently supplies Medtronic's Kyphon Xpander Inflation Syringes used in balloon kyphoplasty procedures and Kyphon KyphoFlex unipedicular steerable balloon catheter for treating vertebral compression fractures.
The Medtronic portfolio of pain therapies includes spinal cord stimulation, vertebral augmentation, nerve ablation, bone tumor ablation, and targeted drug delivery. The addition of an advanced steerable solution for BVNA expands this portfolio to directly meet the growing demand for this expanded therapy option.
